Literature DB >> 2720005

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

Y Kazahaya1, K Akimoto, S Otsuki.   

Abstract

Intracerebral dialysis was used to study the mechanism underlying behavioral sensitization. Rats were divided into two groups: a control group that received intraperitoneal injections of saline and an experimental group that was given methamphetamine (MAP) (4 mg/kg) once a day for 14 days. Seven days after the last injection, dopamine (DA) and its metabolites were measured in striatal dialysates obtained from awake freely moving rats. A challenge injection of MAP (4 mg/kg) caused a marked increase in the extracellular concentrations of DA, and the extent of the increase was significantly greater in MAP-pretreated rats than in the saline-pretreated controls. A challenge injection of cocaine (20 mg/kg) also caused a significantly greater increase in extracellular DA levels in MAP-pretreated rats than in saline-pretreated rats. These results suggest that an enhancement in striatal DA efflux may play an important role in MAP-induced behavioral sensitization and cross-sensitization to cocaine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2720005     DOI: 10.1016/0006-3223(89)90270-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  19 in total

1.  Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamine.

Authors:  Kevin D Lominac; Arianne D Sacramento; Karen K Szumlinski; Tod E Kippin
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 2.  Stimulant-induced psychosis and schizophrenia: the role of sensitization.

Authors:  Hiroshi Ujike
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

3.  One-trial cocaine-induced behavioral sensitization in preweanling rats: role of contextual stimuli.

Authors:  Matthew S Herbert; Taleen Der-Ghazarian; Alexandria G Palmer; Sanders A McDougall
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

4.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine.

Authors:  H Ujike; K Akiyama; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption.

Authors:  Angela C Scibelli; Carrie S McKinnon; Cheryl Reed; Sue Burkhart-Kasch; Na Li; Harue Baba; Jeanna M Wheeler; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

7.  Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats.

Authors:  P E Paulson; T E Robinson
Journal:  Synapse       Date:  1995-01       Impact factor: 2.562

8.  Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms.

Authors:  Subramaniam Jayanthi; Michael T McCoy; Billy Chen; Jonathan P Britt; Saїd Kourrich; Hau-Jie Yau; Bruce Ladenheim; Irina N Krasnova; Antonello Bonci; Jean Lud Cadet
Journal:  Biol Psychiatry       Date:  2013-10-16       Impact factor: 13.382

9.  Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.

Authors:  J F Marshall; S J O'Dell; F B Weihmuller
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.

Authors:  H Ujike; T Onoue; K Akiyama; T Hamamura; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.